<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00977938</url>
  </required_header>
  <id_info>
    <org_study_id>HCRIG080186</org_study_id>
    <nct_id>NCT00977938</nct_id>
  </id_info>
  <brief_title>The Dual Antiplatelet Therapy Study (DAPT Study)</brief_title>
  <official_title>A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baim Institute for Clinical Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bristol-Myers Squibb</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sanofi-Synthelabo</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cordis Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eli Lilly and Company</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Daiichi Sankyo, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Baim Institute for Clinical Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The DAPT Study is a double blind randomized controlled trial intended to determine the
      appropriate duration for dual antiplatelet therapy (the combination of aspirin and a second
      anti-clotting medication) as well as the safety and effectiveness of dual antiplatelet
      therapy to protect patients from stent thrombosis and major adverse cardiovascular and
      cerebrovascular events (MACCE) following the implantation of drug-eluting coronary stents.
      Similar analysis will be conducted in a smaller cohort of bare metal coronary stent - treated
      subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects with ischemic heart disease due to stenotic lesions in either native coronary
      arteries or coronary artery bypass grafts undergoing percutaneous coronary intervention (PCI)
      with stent placement and no contraindications to prolonged dual antiplatelet therapy are
      eligible to be enrolled in the study.

      All enrolled subjects will undergo PCI with stent placement. All enrolled subjects will be
      treated with either an FDA-approved drug eluting stent(s) (DES) or an FDA-approved bare metal
      stent(s) (BMS) (per their respective Instructions for Use) and assigned to 12 months of open
      label FDA-approved thienopyridine treatment in addition to aspirin. Operators will select the
      thienopyridine according to the package insert. Thienopyridine treatment dose will be
      according to the standard of practice and prescribing information for the selected
      medication. Aspirin treatment will be 75-325 mg for the first 6 months after the procedure
      and 75-162 mg subsequently, to be continued indefinitely. All DES or BMS subjects who are
      treated with 12 months of dual antiplatelet therapy post index procedure and who are event
      free per protocol will be eligible for randomization to either placebo (12 m DAPT Study arm)
      or an additional 18 months of thienopyridine treatment (30 m DAPT Study arm). Both arms will
      continue aspirin therapy.

      Up to four (4) separate post-market approval studies will be allowed to incorporate the
      randomized design of the DAPT Study for a subset of subjects who may then be contributed for
      the DAPT Study analyses.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MACCE (Death, Myocardial Infarction or Stroke) - Randomized DES ITT</measure>
    <time_frame>18 months (12-30 months post-index procedure)</time_frame>
    <description>The coprimary efficacy endpoints were the cumulative incidence of MACCE and the cumulative incidence of ARC definite or probable stent thrombosis within randomized DES ITT patients between 12 and 30 months post procedure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Definite or Probable Stent Thrombosis (ST) - Randomized DES ITT</measure>
    <time_frame>18 months (12-30 months post-index procedure)</time_frame>
    <description>The coprimary efficacy endpoints were the cumulative incidence of MACCE and the cumulative incidence of definite or probable ST within randomized DES ITT patients between 12 and 30 months post procedure. ST was assessed according to the Academic Research Consortium (ARC) definitions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>GUSTO Severe or Moderate Bleeding - Randomized DES ITT</measure>
    <time_frame>18 months (12-30 months post-index procedure)</time_frame>
    <description>The primary safety endpoint was moderate or severe bleeding within randomized DES ITT patients between 12 and 30 months post procedure. Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACCE (Death, Myocardial Infarction or Stroke) - Propensity Matched DES vs. BMS</measure>
    <time_frame>33 months (0-33 months post-index procedure)</time_frame>
    <description>Secondary powered endpoint</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Definite or Probable Stent Thrombosis (ST) - Propensity Matched DES vs. BMS</measure>
    <time_frame>33 months (0-33 months post-index procedure)</time_frame>
    <description>Secondary powered endpoint</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACCE (Death, Myocardial Infarction or Stroke) - Randomized DES ITT</measure>
    <time_frame>21 months (12-33 months post-index procedure)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Definite or Probable Stent Thrombosis (ST) - Randomized DES ITT</measure>
    <time_frame>21 months (12-33 months post-index procedure)</time_frame>
    <description>ST was assessed according to the Academic Research Consortium (ARC) definitions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GUSTO Severe or Moderate Bleeding - Randomized DES ITT</measure>
    <time_frame>21 months (12-33 months post-index procedure)</time_frame>
    <description>Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACCE (Death, Myocardial Infarction or Stroke) - Randomized BMS ITT</measure>
    <time_frame>18 months (12-30 months post-index procedure)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Definite or Probable Stent Thrombosis (ST) - Randomized BMS ITT</measure>
    <time_frame>18 months (12-30 months post-index procedure)</time_frame>
    <description>ST was assessed according to the Academic Research Consortium (ARC) definitions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GUSTO Severe or Moderate Bleeding - Randomized BMS ITT</measure>
    <time_frame>18 months (12-30 months post-index procedure)</time_frame>
    <description>Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACCE (Death, Myocardial Infarction or Stroke) - Randomized BMS ITT</measure>
    <time_frame>21 months (12-33 months post-index procedure)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Definite or Probable Stent Thrombosis (ST) - Randomized BMS ITT</measure>
    <time_frame>21 months (12-33 months post-index procedure)</time_frame>
    <description>ST was assessed according to the Academic Research Consortium (ARC) definitions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GUSTO Severe or Moderate Bleeding - Randomized BMS ITT</measure>
    <time_frame>21 months (12-33 months post-index procedure)</time_frame>
    <description>Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25682</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>12m DAPT Study Arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This population consists of subjects enrolled in the study who are free from death, MI, stroke, repeat coronary revascularization, major bleeding, and ST 12 months after stent implantation and who are compliant with 12 months of dual antiplatelet therapy following stent implantation and who are subsequently randomized to receive 18 months of placebo treatment in addition to aspirin.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>30m DAPT Study Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This population consists of subjects enrolled in the study who are free from death, MI, stroke, repeat coronary revascularization, major bleeding, and ST 12 months after stent implantation and who are compliant with 12 months of dual antiplatelet therapy following stent implantation and who are subsequently randomized to receive an additional 18 months of thienopyridine treatment in addition to aspirin.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo &amp; Aspirin</intervention_name>
    <arm_group_label>12m DAPT Study Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clopidogrel &amp; Aspirin, Prasugrel &amp; Aspirin</intervention_name>
    <arm_group_label>30m DAPT Study Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (Enrollment):

          1. Subject is &gt; 18 years of age.

          2. Subjects undergoing percutaneous intervention with stent deployment (or has w/in 24
             hours).

          3. Subjects without known contraindication to dual antiplatelet therapy for at least 30
             months after enrollment and stent implantation.

          4. The subject has consented to participate and has authorized the collection and release
             of his medical information by signing the &quot;Patient Informed Consent Form&quot;. The
             informed consent will be valid for the duration of the trial or until the subject
             withdraws.

        Inclusion Criterion (Randomization at 12 months):

        1. Subject, at 12 months, is free from death, MI, stroke, repeat coronary
        revascularization, major bleeding, and stent thrombosis and has been compliant with dual
        antiplatelet therapy following stent implantation.

        Exclusion Criteria (Enrollment):

          1. Index procedure stent placement with stent diameter &lt;2.25 mm or &gt;4.0 mm.

          2. Pregnant women.

          3. Planned surgery necessitating discontinuation of antiplatelet therapy within the 30
             months following enrollment.

          4. Current medical condition with a life expectancy of less than 3 years.

          5. Concurrent enrollment in another device or drug study whose protocol specifically
             excludes concurrent enrollment or that involves blinded placement of a DES or BMS
             other than those included as DAPT Study devices. The subject may only be enrolled in
             the DAPT Study once.

          6. Subjects on warfarin or similar anticoagulant therapy.

          7. Subjects with hypersensitivity or allergies to one of the drugs or components
             indicated in the Instructions for Use for the device implanted.

          8. Subjects unable to give informed consent.

          9. Subject treated with both DES and BMS during the index procedure.

        Exclusion Criteria (Randomization at 12 months):

          1. Pregnant women.

          2. Subject switched thienopyridine type or dose within 6 months prior to randomization.

          3. Percutaneous coronary intervention or cardiac surgery between 6 weeks post index
             procedure and randomization.

          4. Planned surgery necessitating discontinuation of antiplatelet therapy within the 21
             months following randomization.

          5. Current medical condition with a life expectancy of less than 3 years.

          6. Subjects on warfarin or similar anticoagulant therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura Mauri, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dean Kereiakes, MD, FACC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Christ Hospital Heart and Vascular Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Thomas Hospital</name>
      <address>
        <city>Fairhope</city>
        <state>Alabama</state>
        <zip>36532</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Gilbert Medical Center</name>
      <address>
        <city>Gilbert</city>
        <state>Arizona</state>
        <zip>85297</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart &amp; Vascular Center of Arizona</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scottsdale Health Care</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85258</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NEA Baptist Clinic</name>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <zip>72401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Arkansas (Central VA) for Medical Science</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arkansas Heart Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>California Cardiovascular Consultants/ Washington Hospital</name>
      <address>
        <city>Fremont</city>
        <state>California</state>
        <zip>94538</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Foundation for Cardiovascular Medicine</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy General Hospital</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UC San Diego Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103-8784</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>California Pacific Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Medical Center- CA</name>
      <address>
        <city>Stockton</city>
        <state>California</state>
        <zip>95204-6088</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Torrance Memorial Medical Center / Vasek Polak Research Program</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harbor - UCLA Medical Center</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90509</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Center of Aurora</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Connecticut Clinical Research, LLC</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <zip>06606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bridgeport Hospital</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <zip>06610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Medical Center</name>
      <address>
        <city>Stamford</city>
        <state>Connecticut</state>
        <zip>06905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington Hospital Center</name>
      <address>
        <city>Washington, D.C.</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Palm Beach Heart Research Institute</name>
      <address>
        <city>Atlantis</city>
        <state>Florida</state>
        <zip>33462</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bay Area Cardiology Associates/ Brandon Regional Hospital</name>
      <address>
        <city>Brandon</city>
        <state>Florida</state>
        <zip>33511</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jacksonville Heart Center</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Watson Clinic Center for Research</name>
      <address>
        <city>Lakeland</city>
        <state>Florida</state>
        <zip>33805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diagnostic Cardiology Associates</name>
      <address>
        <city>Lauderdale Lakes</city>
        <state>Florida</state>
        <zip>33313</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Melbourne Internal Medicine Assoc</name>
      <address>
        <city>Melbourne</city>
        <state>Florida</state>
        <zip>32901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Hospital of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Munroe Regional Medical Center</name>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <zip>34471</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ocala Regional Medical Center</name>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <zip>34480</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Hospital</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sacred Heart Hospital</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tallahassee Memorial Hospital</name>
      <address>
        <city>Tallahassee</city>
        <state>Florida</state>
        <zip>32308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pepin Heart Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Winter Haven Hospital</name>
      <address>
        <city>Winter Haven</city>
        <state>Florida</state>
        <zip>33881</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital Midtown</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piedmont Hospital Research Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Center Central Georgia</name>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <zip>31201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Redmond Regional Hospital</name>
      <address>
        <city>Rome</city>
        <state>Georgia</state>
        <zip>30165</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advocate Good Shephard Hospital</name>
      <address>
        <city>Barrington</city>
        <state>Illinois</state>
        <zip>60010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jesse Brown VA Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital- IL</name>
      <address>
        <city>Downers Grove</city>
        <state>Illinois</state>
        <zip>60515</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Elmhurst Memorial Hospital</name>
      <address>
        <city>Elmhurst</city>
        <state>Illinois</state>
        <zip>60126</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heartland Education and Research Foundation</name>
      <address>
        <city>Joliet</city>
        <state>Illinois</state>
        <zip>60435</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Care Research Foundation</name>
      <address>
        <city>Mokena</city>
        <state>Illinois</state>
        <zip>60448</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Edward Heart Hospital</name>
      <address>
        <city>Naperville</city>
        <state>Illinois</state>
        <zip>60540</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midwest Cardiovascular Research and Education Foundation</name>
      <address>
        <city>Elkhart</city>
        <state>Indiana</state>
        <zip>46541</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Heart Center of Indiana, LLC</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46290</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Indiana Cardiovascular Physicians, P.C.</name>
      <address>
        <city>Valparaiso</city>
        <state>Indiana</state>
        <zip>46383</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McFarland Clinic PC</name>
      <address>
        <city>Ames</city>
        <state>Iowa</state>
        <zip>50010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Hospital - Cedar Rapids</name>
      <address>
        <city>Cedar Rapids</city>
        <state>Iowa</state>
        <zip>52403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iowa Heart Center</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50266</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kings Daughters Medical Center</name>
      <address>
        <city>Ashland</city>
        <state>Kentucky</state>
        <zip>41101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tulane University Medical School</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northeast Cardiology Associates</name>
      <address>
        <city>Bangor</city>
        <state>Maine</state>
        <zip>04401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maine Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sinai Hospital at Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Union Memorial Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shah Associates, LLC</name>
      <address>
        <city>Prince Frederick</city>
        <state>Maryland</state>
        <zip>20678</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peninsula Regional Medical Center</name>
      <address>
        <city>Salisbury</city>
        <state>Maryland</state>
        <zip>21804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington Adventist Hospital</name>
      <address>
        <city>Takoma Park</city>
        <state>Maryland</state>
        <zip>20912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lahey Clinic Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cape Cod Hospital</name>
      <address>
        <city>Hyannis</city>
        <state>Massachusetts</state>
        <zip>02601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMass Memorial Medical Center</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bay Regional Medical Center</name>
      <address>
        <city>Bay City</city>
        <state>Michigan</state>
        <zip>48708</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harper University Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201-2018</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital Heart &amp; Vascular Institute</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Borgess Medical Center</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph Mercy-PTCMI</name>
      <address>
        <city>Pontiac</city>
        <state>Michigan</state>
        <zip>48341</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073-6769</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Covenant Medical Center</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Great Lakes Heart &amp; Vascular Institute, PC</name>
      <address>
        <city>Saint Joseph</city>
        <state>Michigan</state>
        <zip>49085</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Munson Medical Center</name>
      <address>
        <city>Traverse City</city>
        <state>Michigan</state>
        <zip>49684</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beaumont Hospital Troy</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48085</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic - Saint Marys Hospital</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Minnesota Heart Center at St. Cloud Hospital</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hattiesburg Clinic</name>
      <address>
        <city>Hattiesburg</city>
        <state>Mississippi</state>
        <zip>39401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates Research LLC</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Hospital Mid America Heart Institute</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kansas City Heart Foundation</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Kansas City Hospital</name>
      <address>
        <city>North Kansas City</city>
        <state>Missouri</state>
        <zip>64116</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110-1093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Louis University Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. John's Mercy Medical Center</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. John's Medical Institute</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nebraska Heart Institute</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68526</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alegent Health / Bergan Mercy Hospital</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Creighton University</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catholic Medical Center</name>
      <address>
        <city>Manchester</city>
        <state>New Hampshire</state>
        <zip>03102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cooper University Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates of the Delaware Valley, PA</name>
      <address>
        <city>Haddon Heights</city>
        <state>New Jersey</state>
        <zip>08035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamilton Cardiology Associates</name>
      <address>
        <city>Hamilton</city>
        <state>New Jersey</state>
        <zip>08690</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valley Hospital</name>
      <address>
        <city>Hawthorne</city>
        <state>New Jersey</state>
        <zip>07506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMDNJ - Robert Wood Johnson Medical School</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Michaels Hospital</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Presbyterian Heart Group</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SJH Cardiology Associates</name>
      <address>
        <city>Liverpool</city>
        <state>New York</state>
        <zip>13088</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Winthrop University Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hudson Valley Heart Center</name>
      <address>
        <city>Poughkeepsie</city>
        <state>New York</state>
        <zip>12601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Medical Center</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794-8167</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Elizabeth's Medical Center- NY</name>
      <address>
        <city>Utica</city>
        <state>New York</state>
        <zip>13501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westchester Medical Center</name>
      <address>
        <city>Valhalla</city>
        <state>New York</state>
        <zip>10595</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asheville Cardiology Associates</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28802</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Heart Specialists</name>
      <address>
        <city>Gastonia</city>
        <state>North Carolina</state>
        <zip>28054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Cardiology Associates</name>
      <address>
        <city>High Point</city>
        <state>North Carolina</state>
        <zip>27262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Heart Association</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Forsyth Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157-1045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MeritCare Medical Center</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Altru Health System</name>
      <address>
        <city>Grand Forks</city>
        <state>North Dakota</state>
        <zip>58206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Lindner Clinical Trial Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267-0542</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Riverside Methodist</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Elyria Memorial Hospital</name>
      <address>
        <city>Elyria</city>
        <state>Ohio</state>
        <zip>44035</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Frederick C Smith Clinic dba Smith Clinic</name>
      <address>
        <city>Marion</city>
        <state>Ohio</state>
        <zip>43302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Ohio Cardiology</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43615</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midwest Regional Medical Center</name>
      <address>
        <city>Midwest City</city>
        <state>Oklahoma</state>
        <zip>73110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oklahoma Foundation for CV Research</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Hospital/ Providence Heart Hospital</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Sciences University Hospital</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239-3098</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abington Memorial Hospital</name>
      <address>
        <city>Abington</city>
        <state>Pennsylvania</state>
        <zip>19001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chambersburg Hospital</name>
      <address>
        <city>Chambersburg</city>
        <state>Pennsylvania</state>
        <zip>17201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Clinic</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Doylestown Hospital</name>
      <address>
        <city>Doylestown</city>
        <state>Pennsylvania</state>
        <zip>18901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pinnacle Health Hospital</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Conemaugh Memorial Medical Center</name>
      <address>
        <city>Johnstown</city>
        <state>Pennsylvania</state>
        <zip>15905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UPMC Presbyterian Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Donald Guthrie Foundation for Education and Research</name>
      <address>
        <city>Sayre</city>
        <state>Pennsylvania</state>
        <zip>18840</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berks Cardiologists</name>
      <address>
        <city>Wyomissing</city>
        <state>Pennsylvania</state>
        <zip>19610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>York Hospital (PA)</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miriam Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02904</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AnMed Health</name>
      <address>
        <city>Anderson</city>
        <state>South Carolina</state>
        <zip>29621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Black Hills Research- Rapid City Regional</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Central Heart Institute</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanford USD Medical Center</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chattanooga Heart - East Third Street</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chattanooga Heart Institute</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centennial Heart Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Heart</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capital Cardiovascular Research Institute</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78745</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Cardiovascular</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78758</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Veteran's Affairs Medical Center- Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CRSTI Research</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UT Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Methodist DeBakey Heart &amp; Vascular Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Dallas Research Associates</name>
      <address>
        <city>McKinney</city>
        <state>Texas</state>
        <zip>75069</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Dallas Research Associate</name>
      <address>
        <city>McKinney</city>
        <state>Texas</state>
        <zip>75069</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Heart Hospital / Baylor Plano</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scott and White Healthcare - Round Rock</name>
      <address>
        <city>Round Rock</city>
        <state>Texas</state>
        <zip>78665</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>TexSan Heart Hospital</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mother Frances Hospital</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Healthcare Network</name>
      <address>
        <city>Waco</city>
        <state>Texas</state>
        <zip>76712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84157-7000</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rockingham Memorial Hospital</name>
      <address>
        <city>Harrisonburg</city>
        <state>Virginia</state>
        <zip>22801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lynchburg General Hospital</name>
      <address>
        <city>Lynchburg</city>
        <state>Virginia</state>
        <zip>24501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sentara, Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carilion Clinic</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates, Ltd.</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <zip>23454</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Winchester Medical Center</name>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <zip>22601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence St. Peter Hospital</name>
      <address>
        <city>Olympia</city>
        <state>Washington</state>
        <zip>98506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195-8422</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inland Cardiology Associates</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sacred Heart Medical Center</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CaRE Foundation, Inc.</name>
      <address>
        <city>Wausau</city>
        <state>Wisconsin</state>
        <zip>54401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincents Hospital Sydney</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Eastern Heart</name>
      <address>
        <city>Randwick</city>
        <state>New South Wales</state>
        <zip>2031</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Alfred Hospital</name>
      <address>
        <city>Prahran</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fremantle Hospital</name>
      <address>
        <city>Fremantle</city>
        <state>Western Australia</state>
        <zip>6160</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Mount Hospital</name>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <zip>6009</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Perth Hospital</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <zip>6000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Monash Heart</name>
      <address>
        <city>Clayton</city>
        <zip>3168</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Vincents Hospital Melbourne</name>
      <address>
        <city>Fitzroy</city>
        <zip>3065</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice Hradec Kralove</name>
      <address>
        <city>Hradec Kralove</city>
        <zip>500 05</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krajska karlovarska nemocnice a.s.</name>
      <address>
        <city>Karlovy Vary</city>
        <zip>360 66</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrum pro choroby srdce a cev</name>
      <address>
        <city>Kromeriz</city>
        <zip>767 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mestska nemocnice Ostrava</name>
      <address>
        <city>Ostrava</city>
        <zip>701 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krajska nemocnice T. Bati a.s.</name>
      <address>
        <city>Zlin</city>
        <zip>76275</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Saint Louis</name>
      <address>
        <city>La Rochelle</city>
        <zip>17000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Saint Philibert</name>
      <address>
        <city>Lomme</city>
        <zip>59462</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nouvelles Cliniques Nantaises</name>
      <address>
        <city>Nantes</city>
        <zip>44277</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique les Franciscaines</name>
      <address>
        <city>Nimes</city>
        <zip>30000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Bichat</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Sud</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Chatiliez Tourcoing</name>
      <address>
        <city>Tourcoing</city>
        <zip>59208</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Emil von Behring</name>
      <address>
        <city>Berlin</city>
        <state>BE</state>
        <zip>1</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Schleswig-Holstein - PS</name>
      <address>
        <city>Luebeck</city>
        <state>SH</state>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vivantes Klinikum im Friedrichshain</name>
      <address>
        <city>Berlin</city>
        <zip>10249</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vivantes-Klinikum Neukoelin</name>
      <address>
        <city>Berlin</city>
        <zip>12351</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vivantes-Klinikum Neukoelln</name>
      <address>
        <city>Berlin</city>
        <zip>13437</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vivantes-Humboldt Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>13509</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Elbe-Kliniken Stade-Buxtehude GmbH</name>
      <address>
        <city>Buxtehude</city>
        <zip>21614</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Dresden</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik St. Georg</name>
      <address>
        <city>Hamburg</city>
        <zip>20099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Leipzig GmbH</name>
      <address>
        <city>Leipzig</city>
        <zip>4289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Elbe-Kliniken Stade-Buxtehude GmbH</name>
      <address>
        <city>Stade</city>
        <zip>21682</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gottsegen Gyorgy Orszagos Kardiologiai Intezet</name>
      <address>
        <city>Budapest</city>
        <zip>1096</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Josa Andras Oktato Korhaz Nonprofit Kft</name>
      <address>
        <city>Nyiregyhaza</city>
        <zip>4400</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pecsi Tudomanyegyetem Klinikai Kozpont</name>
      <address>
        <city>Pecs</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szegedi Tudomanyegyetem Szent-Gyorgyi Klinikai Kozpont</name>
      <address>
        <city>Szeged</city>
        <zip>6720</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zala Megyei Korhaz</name>
      <address>
        <city>Zalaegerszeg</city>
        <zip>8900</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Angiography</name>
      <address>
        <city>Epsom</city>
        <state>Auckland</state>
        <zip>00000</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore Hospital</name>
      <address>
        <city>Auckland</city>
        <zip>0622</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ascot Hospital</name>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Middlemore Hospital</name>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christchurch Hospital</name>
      <address>
        <city>Christchurch</city>
        <zip>8001</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Waikato Hospital</name>
      <address>
        <city>Hamilton</city>
        <zip>3240</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nelson Hospital</name>
      <address>
        <city>Nelson</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wellington Hospital</name>
      <address>
        <city>Wellington</city>
        <zip>6021</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wakefield Hospital</name>
      <address>
        <city>Wellington</city>
        <zip>6039</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uniwersyteck Szpital Klin. w Bialymstoku</name>
      <address>
        <city>Bialystok</city>
        <zip>15-276</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wielospecj. Szpital Miejski im.dr.E.Warminskiego-SPZOZ</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-826</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NZOZ Centrum Medyczne Beluga-Med</name>
      <address>
        <city>Krakow</city>
        <zip>30-069</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Uniwersytecki w Krakowie</name>
      <address>
        <city>Krakow</city>
        <zip>31-501</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SPSK nr 2 Pomorskiej Akademii Medycznej w Szczecinie</name>
      <address>
        <city>Szczecin</city>
        <zip>70-111</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polsko-Amerykanskie Kliniki Serca.American Heart of Poland S</name>
      <address>
        <city>Ustron</city>
        <zip>43-450</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instytut Kardiologii im. Kardynala St. Wyszynskiego</name>
      <address>
        <city>Warszawa</city>
        <zip>04-637</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centrul Clinic de Urgenta de Boli Cardiovasculare al Armatei</name>
      <address>
        <city>Bucuresti</city>
        <zip>10242</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Urgenta Bucuresti</name>
      <address>
        <city>Bucuresti</city>
        <zip>14461</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inst. Urgenta Boli Cardiovasculare Prof. Dr. C.C. Iliescu</name>
      <address>
        <city>Bucuresti</city>
        <zip>22328</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institutul de Urgenta pentru Boli Cardiovasculare Prof. Dr.</name>
      <address>
        <city>Bucuresti</city>
        <zip>22328</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Universitar de Urgenta Bucuresti</name>
      <address>
        <city>Bucuresti</city>
        <zip>50098</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institutul Inimii Niculae Stancioiu Cluj-Napoca</name>
      <address>
        <city>Cluj-Napoca</city>
        <zip>400001</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institutul de Boli Cardiovasculare si Transplant Targu Mures</name>
      <address>
        <city>Targu Mures</city>
        <zip>540136</zip>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wycombe General Hospital</name>
      <address>
        <city>High Wycombe</city>
        <state>Bucks</state>
        <zip>HP11 2TT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Papworth Hospital</name>
      <address>
        <city>Cambridge</city>
        <state>Cambs</state>
        <zip>CB3 8RE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Torbay hospital</name>
      <address>
        <city>Torquay</city>
        <state>Devon</state>
        <zip>TQ2 7AA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Bournemouth General Hospital</name>
      <address>
        <city>Bournemouth</city>
        <state>Dorset</state>
        <zip>BH7 7DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Basildon University Hospital</name>
      <address>
        <city>Basildon</city>
        <state>Essex</state>
        <zip>SS16 5NL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barnet Hospital</name>
      <address>
        <city>Barnet</city>
        <state>Herts</state>
        <zip>EN5 3DJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>James Cook Hospital</name>
      <address>
        <city>Middlesborough</city>
        <state>N York</state>
        <zip>TS4 3BW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ninewells Hospital</name>
      <address>
        <city>Dundee</city>
        <state>Scotland</state>
        <zip>DD1 9SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weston General Hospital</name>
      <address>
        <city>Weston Super Mare</city>
        <state>Somerset</state>
        <zip>BS23 4TQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Golden Jubilee National Hospital</name>
      <address>
        <city>Glasgow</city>
        <state>Strath</state>
        <zip>F81 4HX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Peter's Hospital</name>
      <address>
        <city>Chertsey</city>
        <zip>KT16 OPZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Coventry and Warwickshire</name>
      <address>
        <city>Coventry</city>
        <zip>CV2 2DX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ninewells Hospital</name>
      <address>
        <city>Dundee</city>
        <zip>DD1 9SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Infirmary of Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Leicester Glenfield Hospital</name>
      <address>
        <city>Leicester</city>
        <zip>LE3 9QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The London Chest Hospital</name>
      <address>
        <city>London</city>
        <zip>E2 9JX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Freeman Hospital</name>
      <address>
        <city>Newcastle</city>
        <zip>NE7 7AW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Derriford Hospital</name>
      <address>
        <city>Plymouth</city>
        <zip>PL6 8DH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Czechia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>New Zealand</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2009</study_first_submitted>
  <study_first_submitted_qc>September 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2009</study_first_posted>
  <results_first_submitted>September 18, 2015</results_first_submitted>
  <results_first_submitted_qc>September 18, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 22, 2015</results_first_posted>
  <last_update_submitted>May 10, 2017</last_update_submitted>
  <last_update_submitted_qc>May 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute Coronary Syndrome</keyword>
  <keyword>Adverse event</keyword>
  <keyword>Antiplatelet therapy</keyword>
  <keyword>Sirolimus</keyword>
  <keyword>Everolimus</keyword>
  <keyword>Paclitaxel</keyword>
  <keyword>Zotarolimus</keyword>
  <keyword>Bare Metal Stent</keyword>
  <keyword>Drug Eluting Stent</keyword>
  <keyword>Clinical Events Committee</keyword>
  <keyword>Dual antiplatelet therapy</keyword>
  <keyword>Harvard Clinical Research Institute</keyword>
  <keyword>Major Adverse Cardiac and Cerebral Event</keyword>
  <keyword>Major Bleeding</keyword>
  <keyword>Myocardial infarction</keyword>
  <keyword>Myocardial ischemia</keyword>
  <keyword>Percutaneous coronary intervention</keyword>
  <keyword>Stent placement</keyword>
  <keyword>Stent Thrombosis</keyword>
  <keyword>Thienopyridine</keyword>
  <keyword>Clopidogrel</keyword>
  <keyword>Prasugrel</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Clopidogrel</mesh_term>
    <mesh_term>Prasugrel Hydrochloride</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Between 08/13/2009 and 07/01/2011, a total of 25682 patients were enrolled into the DAPT Study either by HCRI (NCT00977938; 14491 pts) or from 1 of 4 PMS studies: Abbott Xience V US (NCT01106534; 2998 pts), Boston Scientific Libert PAS (NCT00997503; 3904 pts), Cordis CYPRESS (NCT00954707; 2029 pts) and Medtronic EDUCATE (NCT01069003; 2260 pts).</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>DES 30-month DAPT</title>
          <description>Of the 22,866 DES enrolled pts, a total of 9,961 pts underwent randomization at 12 months (4,941 to 12m DAPT and 5,020 to 30m DAPT).</description>
        </group>
        <group group_id="P2">
          <title>DES 12-month DAPT</title>
          <description>Of the 22,866 DES enrolled pts, a total of 9,961 pts underwent randomization at 12 months (4,941 to 12m DAPT and 5,020 to 30m DAPT).</description>
        </group>
        <group group_id="P3">
          <title>BMS 30-month DAPT</title>
          <description>Of the 2,816 BMS enrolled pts, a total of 1,687 pts underwent randomization at 12 months (845 to 12-month DAPT and 842 to 30-month DAPT).</description>
        </group>
        <group group_id="P4">
          <title>BMS 12-month DAPT</title>
          <description>Of the 2,816 BMS enrolled pts, a total of 1,687 pts underwent randomization at 12 months (845 to 12-month DAPT and 842 to 30-month DAPT).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Treatment (12-30 mo. Post Procedure)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5020"/>
                <participants group_id="P2" count="4941"/>
                <participants group_id="P3" count="842"/>
                <participants group_id="P4" count="845"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4783"/>
                <participants group_id="P2" count="4716"/>
                <participants group_id="P3" count="796"/>
                <participants group_id="P4" count="784"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="237"/>
                <participants group_id="P2" count="225"/>
                <participants group_id="P3" count="46"/>
                <participants group_id="P4" count="61"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="132"/>
                <participants group_id="P2" count="116"/>
                <participants group_id="P3" count="13"/>
                <participants group_id="P4" count="20"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="88"/>
                <participants group_id="P2" count="91"/>
                <participants group_id="P3" count="30"/>
                <participants group_id="P4" count="37"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Observation (30-33 mo. Post Procedure)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4783"/>
                <participants group_id="P2" count="4716"/>
                <participants group_id="P3" count="796"/>
                <participants group_id="P4" count="784"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4732"/>
                <participants group_id="P2" count="4658"/>
                <participants group_id="P3" count="784"/>
                <participants group_id="P4" count="781"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="58"/>
                <participants group_id="P3" count="12"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="12"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="42"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>DES 30-month DAPT</title>
          <description>Patients who were treated with DES at the index procedure and were randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
        </group>
        <group group_id="B2">
          <title>DES 12-month DAPT</title>
          <description>Patients who were treated with DES at the index procedure and were randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
        </group>
        <group group_id="B3">
          <title>BMS 30-month DAPT</title>
          <description>Patients who were treated with BMS at the index procedure and were randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
        </group>
        <group group_id="B4">
          <title>BMS 12-month DAPT</title>
          <description>Patients who were treated with BMS at the index procedure and were randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5020"/>
            <count group_id="B2" value="4941"/>
            <count group_id="B3" value="842"/>
            <count group_id="B4" value="845"/>
            <count group_id="B5" value="11648"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.84" spread="10.18"/>
                    <measurement group_id="B2" value="61.60" spread="10.12"/>
                    <measurement group_id="B3" value="58.86" spread="10.54"/>
                    <measurement group_id="B4" value="59.18" spread="11.07"/>
                    <measurement group_id="B5" value="61.33" spread="10.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1242"/>
                    <measurement group_id="B2" value="1284"/>
                    <measurement group_id="B3" value="215"/>
                    <measurement group_id="B4" value="184"/>
                    <measurement group_id="B5" value="2925"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3778"/>
                    <measurement group_id="B2" value="3657"/>
                    <measurement group_id="B3" value="627"/>
                    <measurement group_id="B4" value="661"/>
                    <measurement group_id="B5" value="8723"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <description>Race was self-reported</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="252"/>
                    <measurement group_id="B2" value="253"/>
                    <measurement group_id="B3" value="38"/>
                    <measurement group_id="B4" value="33"/>
                    <measurement group_id="B5" value="576"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4480"/>
                    <measurement group_id="B2" value="4428"/>
                    <measurement group_id="B3" value="768"/>
                    <measurement group_id="B4" value="774"/>
                    <measurement group_id="B5" value="10450"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="108"/>
                    <measurement group_id="B2" value="106"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="23"/>
                    <measurement group_id="B5" value="257"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>North America</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4502"/>
                    <measurement group_id="B2" value="4416"/>
                    <measurement group_id="B3" value="509"/>
                    <measurement group_id="B4" value="519"/>
                    <measurement group_id="B5" value="9946"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Europe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="402"/>
                    <measurement group_id="B2" value="405"/>
                    <measurement group_id="B3" value="304"/>
                    <measurement group_id="B4" value="300"/>
                    <measurement group_id="B5" value="1411"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Australia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="12"/>
                    <measurement group_id="B5" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New Zealand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="163"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="91.49" spread="19.74"/>
                    <measurement group_id="B2" value="91.52" spread="19.43"/>
                    <measurement group_id="B3" value="87.99" spread="18.40"/>
                    <measurement group_id="B4" value="88.54" spread="18.77"/>
                    <measurement group_id="B5" value="91.04" spread="19.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.54" spread="5.79"/>
                    <measurement group_id="B2" value="30.55" spread="5.77"/>
                    <measurement group_id="B3" value="29.49" spread="5.18"/>
                    <measurement group_id="B4" value="29.61" spread="5.55"/>
                    <measurement group_id="B5" value="30.40" spread="5.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes Mellitus</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1556"/>
                    <measurement group_id="B2" value="1481"/>
                    <measurement group_id="B3" value="181"/>
                    <measurement group_id="B4" value="173"/>
                    <measurement group_id="B5" value="3391"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertension</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3796"/>
                    <measurement group_id="B2" value="3649"/>
                    <measurement group_id="B3" value="534"/>
                    <measurement group_id="B4" value="543"/>
                    <measurement group_id="B5" value="8522"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Current cigarette smoker or within past year</title>
          <description>Current cigarette smoker or within past year was defined as follows:
HCRI DAPT: current cigarette smoker or within past year
Abbott Xience V: current tobacco user or former tobacco user within the past month
Boston Scientific Liberte PAS: smoking status of current from medical history
Cordis CYPRESS: smoking within 30 days
Medtronic EDUCATE: smoking/tobacco usage = current or within last year</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1222"/>
                    <measurement group_id="B2" value="1210"/>
                    <measurement group_id="B3" value="360"/>
                    <measurement group_id="B4" value="350"/>
                    <measurement group_id="B5" value="3142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Stroke/Transient Ischemic Attack (TIA)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="155"/>
                    <measurement group_id="B2" value="169"/>
                    <measurement group_id="B3" value="43"/>
                    <measurement group_id="B4" value="34"/>
                    <measurement group_id="B5" value="401"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Congestive heart failure</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="238"/>
                    <measurement group_id="B2" value="223"/>
                    <measurement group_id="B3" value="35"/>
                    <measurement group_id="B4" value="28"/>
                    <measurement group_id="B5" value="524"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Peripheral arterial disease</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="284"/>
                    <measurement group_id="B2" value="284"/>
                    <measurement group_id="B3" value="35"/>
                    <measurement group_id="B4" value="46"/>
                    <measurement group_id="B5" value="649"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prior percutaneous coronary intervention (PCI)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1518"/>
                    <measurement group_id="B2" value="1529"/>
                    <measurement group_id="B3" value="150"/>
                    <measurement group_id="B4" value="171"/>
                    <measurement group_id="B5" value="3368"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prior coronary artery bypass graf (CABG)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="568"/>
                    <measurement group_id="B2" value="581"/>
                    <measurement group_id="B3" value="50"/>
                    <measurement group_id="B4" value="50"/>
                    <measurement group_id="B5" value="1249"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prior myocardial infarction (MI)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1092"/>
                    <measurement group_id="B2" value="1026"/>
                    <measurement group_id="B3" value="160"/>
                    <measurement group_id="B4" value="178"/>
                    <measurement group_id="B5" value="2456"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Indication for PCI</title>
          <description>&quot;Unstable angina&quot; includes unstable angina without reported elevation of cardiac enzymes</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>ST elevation MI (STEMI)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="534"/>
                    <measurement group_id="B2" value="511"/>
                    <measurement group_id="B3" value="311"/>
                    <measurement group_id="B4" value="324"/>
                    <measurement group_id="B5" value="1680"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-ST elevation MI (NSTEMI)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="776"/>
                    <measurement group_id="B2" value="767"/>
                    <measurement group_id="B3" value="184"/>
                    <measurement group_id="B4" value="169"/>
                    <measurement group_id="B5" value="1896"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unstable angina</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="838"/>
                    <measurement group_id="B2" value="825"/>
                    <measurement group_id="B3" value="77"/>
                    <measurement group_id="B4" value="81"/>
                    <measurement group_id="B5" value="1821"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stable angina</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1882"/>
                    <measurement group_id="B2" value="1870"/>
                    <measurement group_id="B3" value="199"/>
                    <measurement group_id="B4" value="198"/>
                    <measurement group_id="B5" value="4149"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="990"/>
                    <measurement group_id="B2" value="968"/>
                    <measurement group_id="B3" value="71"/>
                    <measurement group_id="B4" value="73"/>
                    <measurement group_id="B5" value="2102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Any risk factor for stent thrombosis</title>
          <description>Any clinical or lesion-related risk factors for stent thrombosis.
Clinical risk factors for stent thrombosis included:
Acute coronary syndrome (ACS) at presentation
ST elevation MI (STEMI) at presentation
Renal insufficiency or failure
Ejection fraction &lt;30%.
Lesion-related risk factors for stent thrombosis included:
More than two vessels stented
&gt;2 lesions per vessel
Lesion length 30 mm
Bifurcation lesion with side branch 2.5 mm
In-stent restenosis of a DES
Vein bypass graft
Unprotected left main
Thrombus containing lesion
Prior brachytherapy</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2410"/>
                    <measurement group_id="B2" value="2389"/>
                    <measurement group_id="B3" value="568"/>
                    <measurement group_id="B4" value="569"/>
                    <measurement group_id="B5" value="5936"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of treated lesions (per-patient)</title>
          <units>lesions</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.30" spread="0.55"/>
                    <measurement group_id="B2" value="1.29" spread="0.54"/>
                    <measurement group_id="B3" value="1.16" spread="0.40"/>
                    <measurement group_id="B4" value="1.17" spread="0.42"/>
                    <measurement group_id="B5" value="1.28" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of treated vessels (per-patient)</title>
          <units>vessels</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.11" spread="0.33"/>
                    <measurement group_id="B2" value="1.12" spread="0.34"/>
                    <measurement group_id="B3" value="1.03" spread="0.18"/>
                    <measurement group_id="B4" value="1.05" spread="0.23"/>
                    <measurement group_id="B5" value="1.11" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of stents (per-patient)</title>
          <units>stents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.47" spread="0.75"/>
                    <measurement group_id="B2" value="1.45" spread="0.75"/>
                    <measurement group_id="B3" value="1.32" spread="0.60"/>
                    <measurement group_id="B4" value="1.32" spread="0.60"/>
                    <measurement group_id="B5" value="1.44" spread="0.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Minimum stent diameter (per-patient)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;3 mm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2341"/>
                    <measurement group_id="B2" value="2293"/>
                    <measurement group_id="B3" value="201"/>
                    <measurement group_id="B4" value="206"/>
                    <measurement group_id="B5" value="5041"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 mm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2679"/>
                    <measurement group_id="B2" value="2648"/>
                    <measurement group_id="B3" value="641"/>
                    <measurement group_id="B4" value="639"/>
                    <measurement group_id="B5" value="6607"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total stent length (per-patient)</title>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.70" spread="16.77"/>
                    <measurement group_id="B2" value="27.43" spread="17.02"/>
                    <measurement group_id="B3" value="23.96" spread="13.01"/>
                    <measurement group_id="B4" value="23.85" spread="13.12"/>
                    <measurement group_id="B5" value="27.04" spread="16.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Treated Vessel</title>
          <description>The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions</description>
          <units>lesions</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Left main</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left anterior descending (LAD)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2715"/>
                    <measurement group_id="B2" value="2586"/>
                    <measurement group_id="B3" value="308"/>
                    <measurement group_id="B4" value="306"/>
                    <measurement group_id="B5" value="5915"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right coronary artery (RCA)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2153"/>
                    <measurement group_id="B2" value="2057"/>
                    <measurement group_id="B3" value="437"/>
                    <measurement group_id="B4" value="452"/>
                    <measurement group_id="B5" value="5099"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Circumflex</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1473"/>
                    <measurement group_id="B2" value="1506"/>
                    <measurement group_id="B3" value="206"/>
                    <measurement group_id="B4" value="207"/>
                    <measurement group_id="B5" value="3392"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Venous graft</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="154"/>
                    <measurement group_id="B2" value="173"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="25"/>
                    <measurement group_id="B5" value="376"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arterial graft</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Modified ACCAHA lesion class B2 or C</title>
          <description>The 5,020 DES 30-month DAPT patients had a total of 6,594 lesions; The 4,941 DES 12-month DAPT patients had a total of 6,413 lesions; The 842 BMS 30-month DAPT patients had a total of 975 lesions; The 845 BMS 12-month DAPT patients had a total of 991 lesions; The definitions of class B2 and class C lesions according to the modified ACC/AHA criteria</description>
          <units>lesions</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2754"/>
                    <measurement group_id="B2" value="2643"/>
                    <measurement group_id="B3" value="440"/>
                    <measurement group_id="B4" value="450"/>
                    <measurement group_id="B5" value="6287"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>MACCE (Death, Myocardial Infarction or Stroke) - Randomized DES ITT</title>
        <description>The coprimary efficacy endpoints were the cumulative incidence of MACCE and the cumulative incidence of ARC definite or probable stent thrombosis within randomized DES ITT patients between 12 and 30 months post procedure.</description>
        <time_frame>18 months (12-30 months post-index procedure)</time_frame>
        <population>All randomized DES ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 30 months or at last known follow-up, whichever was earlier.</population>
        <group_list>
          <group group_id="O1">
            <title>DES 30-month DAPT</title>
            <description>Patients who were treated with DES at the index procedure and were randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
          </group>
          <group group_id="O2">
            <title>DES 12-month DAPT</title>
            <description>Patients who were treated with DES at the index procedure and were randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
          </group>
        </group_list>
        <measure>
          <title>MACCE (Death, Myocardial Infarction or Stroke) - Randomized DES ITT</title>
          <description>The coprimary efficacy endpoints were the cumulative incidence of MACCE and the cumulative incidence of ARC definite or probable stent thrombosis within randomized DES ITT patients between 12 and 30 months post procedure.</description>
          <population>All randomized DES ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 30 months or at last known follow-up, whichever was earlier.</population>
          <units>percentage of patients (KM estimate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5020"/>
                <count group_id="O2" value="4941"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.34"/>
                    <measurement group_id="O2" value="5.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The primary efficacy analysis was a superiority analysis. We controlled the two-sided family-wise error rate of 0.05 across the two coprimary end points using the HochbergBenjamini method. With this method, the null hypothesis of randomized treatment equivalence is rejected if significance is achieved for both end points at a two-sided alpha level of 0.05 or for one end point at a two-sided alpha level of 0.025.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>P-value was stratified according to geographic region (NA, EU, or AU and NZ), thienopyridine received at the time of randomization, and presence or absence of risk factors for ST; P-value was adjudsted using the Benjamini Hochberg approach.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.71</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.59</ci_lower_limit>
            <ci_upper_limit>0.85</ci_upper_limit>
            <estimate_desc>30-month DAPT vs. 12-month DAPT; HR was stratified according to geographic region (NA, EU, or AU and NZ), thienopyridine drug received at the time of randomization, and presence or absence of risk factors for stent thrombosis.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Definite or Probable Stent Thrombosis (ST) - Randomized DES ITT</title>
        <description>The coprimary efficacy endpoints were the cumulative incidence of MACCE and the cumulative incidence of definite or probable ST within randomized DES ITT patients between 12 and 30 months post procedure. ST was assessed according to the Academic Research Consortium (ARC) definitions.</description>
        <time_frame>18 months (12-30 months post-index procedure)</time_frame>
        <population>All randomized DES ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 30 months or at last known follow-up, whichever was earlier.</population>
        <group_list>
          <group group_id="O1">
            <title>DES 30-month DAPT</title>
            <description>Patients who were treated with DES at the index procedure and were randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
          </group>
          <group group_id="O2">
            <title>DES 12-month DAPT</title>
            <description>Patients who were treated with DES at the index procedure and were randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
          </group>
        </group_list>
        <measure>
          <title>Definite or Probable Stent Thrombosis (ST) - Randomized DES ITT</title>
          <description>The coprimary efficacy endpoints were the cumulative incidence of MACCE and the cumulative incidence of definite or probable ST within randomized DES ITT patients between 12 and 30 months post procedure. ST was assessed according to the Academic Research Consortium (ARC) definitions.</description>
          <population>All randomized DES ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 30 months or at last known follow-up, whichever was earlier.</population>
          <units>percentage of patients (KM estimate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5020"/>
                <count group_id="O2" value="4941"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40"/>
                    <measurement group_id="O2" value="1.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The primary efficacy analysis was a superiority analysis. We controlled the two-sided family-wise error rate of 0.05 across the two coprimary end points using the HochbergBenjamini method. With this method, the null hypothesis of randomized treatment equivalence is rejected if significance is achieved for both end points at a two-sided alpha level of 0.05 or for one end point at a two-sided alpha level of 0.025.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>P-value was stratified according to geographic region (NA, EU, or AU and NZ), thienopyridine received at the time of randomization, and presence or absence of risk factors for ST; P-value was adjudsted using the Benjamini Hochberg approach.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.29</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.17</ci_lower_limit>
            <ci_upper_limit>0.48</ci_upper_limit>
            <estimate_desc>30-month DAPT vs. 12-month DAPT; HR was stratified according to geographic region (NA, EU, or AU and NZ), thienopyridine drug received at the time of randomization, and presence or absence of risk factors for stent thrombosis.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>GUSTO Severe or Moderate Bleeding - Randomized DES ITT</title>
        <description>The primary safety endpoint was moderate or severe bleeding within randomized DES ITT patients between 12 and 30 months post procedure. Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.</description>
        <time_frame>18 months (12-30 months post-index procedure)</time_frame>
        <population>Only patients who could be evaluated were included in this analysis (i.e., patients whose last contact date was 510 days after randomization or who had any adjudicated bleeding event at or before 540 days).</population>
        <group_list>
          <group group_id="O1">
            <title>DES 30-month DAPT</title>
            <description>Patients who were treated with DES at the index procedure and were randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
          </group>
          <group group_id="O2">
            <title>DES 12-month DAPT</title>
            <description>Patients who were treated with DES at the index procedure and were randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
          </group>
        </group_list>
        <measure>
          <title>GUSTO Severe or Moderate Bleeding - Randomized DES ITT</title>
          <description>The primary safety endpoint was moderate or severe bleeding within randomized DES ITT patients between 12 and 30 months post procedure. Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.</description>
          <population>Only patients who could be evaluated were included in this analysis (i.e., patients whose last contact date was 510 days after randomization or who had any adjudicated bleeding event at or before 540 days).</population>
          <units>percentage of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4710"/>
                <count group_id="O2" value="4649"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.53"/>
                    <measurement group_id="O2" value="1.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The primary safety analysis was a noninferiority analysis performed with the use of the FarringtonManning risk-difference approach. Assuming an annualized rate for moderate or severe bleeding of 1.9% and an absolute noninferiority margin of 0.8%, at a one-sided alpha level of significance of 0.025, we calculated that a sample size of 9960 patients would give the study 80% power to detect noninferiority.</non_inferiority_desc>
            <p_value>0.704</p_value>
            <p_value_desc>One-sided P-value for non-inferiority</p_value_desc>
            <method>Farrington-Manning</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.96</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.38</ci_lower_limit>
            <ci_upper_limit>1.53</ci_upper_limit>
            <estimate_desc>30-month DAPT vs. 12-month DAPT</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>MACCE (Death, Myocardial Infarction or Stroke) - Propensity Matched DES vs. BMS</title>
        <description>Secondary powered endpoint</description>
        <time_frame>33 months (0-33 months post-index procedure)</time_frame>
        <population>A subsample created by matching BMS- to DES-treated patients exactly on prevalence of STEMI and then matching on remaining baseline characteristics via propensity score, using a caliper width of 0.10. A BMS-treated patient was matched to a variable number of DES-treated patients without replacement, up to a maximum of 8.</population>
        <group_list>
          <group group_id="O1">
            <title>Propensity-matched DES</title>
            <description>Because patients were not randomized to DES or BMS, DES comparisons vs. BMS on stent thrombosis and MACCE were carried out on sample matched on baseline characteristics via propensity score matching. The analyses were restricted to patients enrolled into the 3 contributing studies that planned to follow all enrolled patients (whether or not a patient was randomized) for 33 months. Patients prematurely withdrawing before 29 months follow-up (earliest allowable follow-up time for the 30-month visit) or before experiencing the endpoint were excluded. A total of 13,257 DES-treated patients were eligible for propensity matching, of whom 8,308 patients were matched to BMS-treated patients (up to 8 DES patients could be matched to a BMS patient; i.e., the BMS:DES matching ratio ranged from 1:1 to 1:8).</description>
          </group>
          <group group_id="O2">
            <title>Propensity-matched BMS</title>
            <description>Because patients were not randomized to DES or BMS, DES comparisons vs. BMS on stent thrombosis and MACCE were carried out on sample matched on baseline characteristics via propensity score matching. The analyses were restricted to patients enrolled into the 3 contributing studies that planned to follow all enrolled patients (whether or not a patient was randomized) for 33 months. Patients prematurely withdrawing before 29 months follow-up (earliest allowable follow-up time for the 30-month visit) or before experiencing the endpoint were excluded. A total of 2,056 BMS-treated patients were eligible for propensity matching, of whom 1,718 were matched to at least one DES-treated patient (a BMS patient could be matched to up to 8 DES patients; i.e., the BMS:DES matching ratio ranged from 1:1 to 1:8).</description>
          </group>
        </group_list>
        <measure>
          <title>MACCE (Death, Myocardial Infarction or Stroke) - Propensity Matched DES vs. BMS</title>
          <description>Secondary powered endpoint</description>
          <population>A subsample created by matching BMS- to DES-treated patients exactly on prevalence of STEMI and then matching on remaining baseline characteristics via propensity score, using a caliper width of 0.10. A BMS-treated patient was matched to a variable number of DES-treated patients without replacement, up to a maximum of 8.</population>
          <units>percentage of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8308"/>
                <count group_id="O2" value="1718"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.37"/>
                    <measurement group_id="O2" value="13.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis was that DAPT patients treated with DES would have MACCE rate between 0 and 33 months post-index procedure that exceeds that of the control arm (patients treated with BMS) by at least a pre-specified absolute margin of .</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin of 2.28% (0.0228)</non_inferiority_desc>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>One-sided P-value for non-inferiority</p_value_desc>
            <method>Nam and Kwon</method>
            <method_desc>P-value was computed for clustered matched pairs based on Nam and Kwon (2009).</method_desc>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-1.82</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>1-Sided</ci_n_sides>
            <ci_upper_limit>0.03</ci_upper_limit>
            <estimate_desc>Weighted RD and 1-sided 97.5% upper CL were computed for clustered matched pairs based on Nam and Kwon (2009).</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Definite or Probable Stent Thrombosis (ST) - Propensity Matched DES vs. BMS</title>
        <description>Secondary powered endpoint</description>
        <time_frame>33 months (0-33 months post-index procedure)</time_frame>
        <population>A subsample created by matching BMS- to DES-treated patients exactly on prevalence of STEMI and then matching on remaining baseline characteristics via propensity score, using a caliper width of 0.10. A BMS-treated patient was matched to a variable number of DES-treated patients without replacement, up to a maximum of 8.</population>
        <group_list>
          <group group_id="O1">
            <title>Propensity-matched DES</title>
            <description>Because patients were not randomized to DES or BMS, DES comparisons vs. BMS on stent thrombosis and MACCE were carried out on sample matched on baseline characteristics via propensity score matching. The analyses were restricted to patients enrolled into the 3 contributing studies that planned to follow all enrolled patients (whether or not a patient was randomized) for 33 months. Patients prematurely withdrawing before 29 months follow-up (earliest allowable follow-up time for the 30-month visit) or before experiencing the endpoint were excluded. A total of 13,257 DES-treated patients were eligible for propensity matching, of whom 8,308 patients were matched to BMS-treated patients (up to 8 DES patients could be matched to a BMS patient; i.e., the BMS:DES matching ratio ranged from 1:1 to 1:8).</description>
          </group>
          <group group_id="O2">
            <title>Propensity-matched BMS</title>
            <description>Because patients were not randomized to DES or BMS, DES comparisons vs. BMS on stent thrombosis and MACCE were carried out on sample matched on baseline characteristics via propensity score matching. The analyses were restricted to patients enrolled into the 3 contributing studies that planned to follow all enrolled patients (whether or not a patient was randomized) for 33 months. Patients prematurely withdrawing before 29 months follow-up (earliest allowable follow-up time for the 30-month visit) or before experiencing the endpoint were excluded. A total of 2,056 BMS-treated patients were eligible for propensity matching, of whom 1,718 were matched to at least one DES-treated patient (a BMS patient could be matched to up to 8 DES patients; i.e., the BMS:DES matching ratio ranged from 1:1 to 1:8).</description>
          </group>
        </group_list>
        <measure>
          <title>Definite or Probable Stent Thrombosis (ST) - Propensity Matched DES vs. BMS</title>
          <description>Secondary powered endpoint</description>
          <population>A subsample created by matching BMS- to DES-treated patients exactly on prevalence of STEMI and then matching on remaining baseline characteristics via propensity score, using a caliper width of 0.10. A BMS-treated patient was matched to a variable number of DES-treated patients without replacement, up to a maximum of 8.</population>
          <units>percentage of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8308"/>
                <count group_id="O2" value="1718"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.70"/>
                    <measurement group_id="O2" value="2.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis was that DAPT patients treated with DES would have stent thrombosis rate between 0 and 33 months post-index procedure that exceeds that of the control arm (patients treated with BMS) by at least a pre-specified absolute margin of .</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin of 0.97% (0.0097)</non_inferiority_desc>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>One-sided P-value for non-inferiority</p_value_desc>
            <method>Nam and Kwon</method>
            <method_desc>P-value was computed for clustered matched pairs based on Nam and Kwon (2009).</method_desc>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-1.05</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>1-Sided</ci_n_sides>
            <ci_upper_limit>-0.27</ci_upper_limit>
            <estimate_desc>Weighted RD and 1-sided 95% upper CL were computed for clustered matched pairs based on Nam and Kwon (2009).</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>MACCE (Death, Myocardial Infarction or Stroke) - Randomized DES ITT</title>
        <time_frame>21 months (12-33 months post-index procedure)</time_frame>
        <population>All randomized DES ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 33 months or at last known follow-up, whichever was earlier.</population>
        <group_list>
          <group group_id="O1">
            <title>DES 30-month DAPT</title>
            <description>Patients who were treated with DES at the index procedure and were randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
          </group>
          <group group_id="O2">
            <title>DES 12-month DAPT</title>
            <description>Patients who were treated with DES at the index procedure and were randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
          </group>
        </group_list>
        <measure>
          <title>MACCE (Death, Myocardial Infarction or Stroke) - Randomized DES ITT</title>
          <population>All randomized DES ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 33 months or at last known follow-up, whichever was earlier.</population>
          <units>percentage of patients (KM estimate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5020"/>
                <count group_id="O2" value="4941"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.62"/>
                    <measurement group_id="O2" value="6.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.82</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.70</ci_lower_limit>
            <ci_upper_limit>0.97</ci_upper_limit>
            <estimate_desc>30-month DAPT vs. 12-month DAPT; HR was stratified according to geographic region (NA, EU, or AU and NZ), thienopyridine drug received at the time of randomization, and presence or absence of risk factors for stent thrombosis</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Definite or Probable Stent Thrombosis (ST) - Randomized DES ITT</title>
        <description>ST was assessed according to the Academic Research Consortium (ARC) definitions.</description>
        <time_frame>21 months (12-33 months post-index procedure)</time_frame>
        <population>All randomized DES ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 33 months or at last known follow-up, whichever was earlier.</population>
        <group_list>
          <group group_id="O1">
            <title>DES 30-month DAPT</title>
            <description>Patients who were treated with DES at the index procedure and were randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
          </group>
          <group group_id="O2">
            <title>DES 12-month DAPT</title>
            <description>Patients who were treated with DES at the index procedure and were randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
          </group>
        </group_list>
        <measure>
          <title>Definite or Probable Stent Thrombosis (ST) - Randomized DES ITT</title>
          <description>ST was assessed according to the Academic Research Consortium (ARC) definitions.</description>
          <population>All randomized DES ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 33 months or at last known follow-up, whichever was earlier.</population>
          <units>percentage of patients (KM estimate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5020"/>
                <count group_id="O2" value="4941"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.69"/>
                    <measurement group_id="O2" value="1.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.45</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.29</ci_lower_limit>
            <ci_upper_limit>0.69</ci_upper_limit>
            <estimate_desc>30-month DAPT vs. 12-month DAPT; HR was stratified according to geographic region (NA, EU, or AU and NZ), thienopyridine drug received at the time of randomization, and presence or absence of risk factors for stent thrombosis</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>GUSTO Severe or Moderate Bleeding - Randomized DES ITT</title>
        <description>Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.</description>
        <time_frame>21 months (12-33 months post-index procedure)</time_frame>
        <population>Only patients who could be evaluated were included in this analysis (i.e., patients whose last contact date was 600 days after randomization or who had any adjudicated bleeding event at or before 630 days).</population>
        <group_list>
          <group group_id="O1">
            <title>DES 30-month DAPT</title>
            <description>Patients who were treated with DES at the index procedure and were randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
          </group>
          <group group_id="O2">
            <title>DES 12-month DAPT</title>
            <description>Patients who were treated with DES at the index procedure and were randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
          </group>
        </group_list>
        <measure>
          <title>GUSTO Severe or Moderate Bleeding - Randomized DES ITT</title>
          <description>Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.</description>
          <population>Only patients who could be evaluated were included in this analysis (i.e., patients whose last contact date was 600 days after randomization or who had any adjudicated bleeding event at or before 630 days).</population>
          <units>percentage of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4525"/>
                <count group_id="O2" value="4476"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.74"/>
                    <measurement group_id="O2" value="1.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.86</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.24</ci_lower_limit>
            <ci_upper_limit>1.48</ci_upper_limit>
            <estimate_desc>30-month DAPT vs. 12-month DAPT</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>MACCE (Death, Myocardial Infarction or Stroke) - Randomized BMS ITT</title>
        <time_frame>18 months (12-30 months post-index procedure)</time_frame>
        <population>All randomized BMS ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 30 months or at last known follow-up, whichever was earlier.</population>
        <group_list>
          <group group_id="O1">
            <title>BMS 30-month DAPT</title>
            <description>Patients who were treated with BMS at the index procedure and were randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
          </group>
          <group group_id="O2">
            <title>BMS 12-month DAPT</title>
            <description>Patients who were treated with BMS at the index procedure and were randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
          </group>
        </group_list>
        <measure>
          <title>MACCE (Death, Myocardial Infarction or Stroke) - Randomized BMS ITT</title>
          <population>All randomized BMS ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 30 months or at last known follow-up, whichever was earlier.</population>
          <units>percentage of patients (KM estimate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="842"/>
                <count group_id="O2" value="845"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.04"/>
                    <measurement group_id="O2" value="4.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This analysis was not powered.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.722</p_value>
            <p_value_desc>This analysis was not powered. P-value was stratified according to geographic region, thienopyridine received at the time of randomization, and presence or absence of risk factors for ST; P-value was adjudsted using the Benjamini Hochberg approach.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.92</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.57</ci_lower_limit>
            <ci_upper_limit>1.47</ci_upper_limit>
            <estimate_desc>30-month DAPT vs. 12-month DAPT; HR was stratified according to geographic region (NA, EU, or AU and NZ), thienopyridine drug received at the time of randomization, and presence or absence of risk factors for stent thrombosis.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Definite or Probable Stent Thrombosis (ST) - Randomized BMS ITT</title>
        <description>ST was assessed according to the Academic Research Consortium (ARC) definitions.</description>
        <time_frame>18 months (12-30 months post-index procedure)</time_frame>
        <population>All randomized BMS ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 30 months or at last known follow-up, whichever was earlier.</population>
        <group_list>
          <group group_id="O1">
            <title>BMS 30-month DAPT</title>
            <description>Patients who were treated with BMS at the index procedure and were randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
          </group>
          <group group_id="O2">
            <title>BMS 12-month DAPT</title>
            <description>Patients who were treated with BMS at the index procedure and were randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
          </group>
        </group_list>
        <measure>
          <title>Definite or Probable Stent Thrombosis (ST) - Randomized BMS ITT</title>
          <description>ST was assessed according to the Academic Research Consortium (ARC) definitions.</description>
          <population>All randomized BMS ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 30 months or at last known follow-up, whichever was earlier.</population>
          <units>percentage of patients (KM estimate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="842"/>
                <count group_id="O2" value="845"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.50"/>
                    <measurement group_id="O2" value="1.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>This analysis was not powered.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.478</p_value>
            <p_value_desc>This analysis was not powered. P-value was stratified according to geographic region, thienopyridine received at the time of randomization, and presence or absence of risk factors for ST; P-value was adjudsted using the Benjamini Hochberg approach.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.49</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.15</ci_lower_limit>
            <ci_upper_limit>1.64</ci_upper_limit>
            <estimate_desc>30-month DAPT vs. 12-month DAPT; HR was stratified according to geographic region (NA, EU, or AU and NZ), thienopyridine drug received at the time of randomization, and presence or absence of risk factors for stent thrombosis.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>GUSTO Severe or Moderate Bleeding - Randomized BMS ITT</title>
        <description>Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.</description>
        <time_frame>18 months (12-30 months post-index procedure)</time_frame>
        <population>Only patients who could be evaluated were included in this analysis (i.e., patients whose last contact date was 510 days after randomization or who had any adjudicated bleeding event at or before 540 days).</population>
        <group_list>
          <group group_id="O1">
            <title>BMS 30-month DAPT</title>
            <description>Patients who were treated with BMS at the index procedure and were randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
          </group>
          <group group_id="O2">
            <title>BMS 12-month DAPT</title>
            <description>Patients who were treated with BMS at the index procedure and were randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
          </group>
        </group_list>
        <measure>
          <title>GUSTO Severe or Moderate Bleeding - Randomized BMS ITT</title>
          <description>Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.</description>
          <population>Only patients who could be evaluated were included in this analysis (i.e., patients whose last contact date was 510 days after randomization or who had any adjudicated bleeding event at or before 540 days).</population>
          <units>percentage of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="790"/>
                <count group_id="O2" value="776"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.03"/>
                    <measurement group_id="O2" value="0.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.706</p_value>
            <method>Farrington-Manning</method>
            <method_desc>No formal hypothesis testing was done.</method_desc>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>1.12</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.06</ci_lower_limit>
            <ci_upper_limit>2.31</ci_upper_limit>
            <estimate_desc>30-month DAPT vs. 12-month DAPT</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>MACCE (Death, Myocardial Infarction or Stroke) - Randomized BMS ITT</title>
        <time_frame>21 months (12-33 months post-index procedure)</time_frame>
        <population>All randomized BMS ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 33 months or at last known follow-up, whichever was earlier.</population>
        <group_list>
          <group group_id="O1">
            <title>BMS 30-month DAPT</title>
            <description>Patients who were treated with BMS at the index procedure and were randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
          </group>
          <group group_id="O2">
            <title>BMS 12-month DAPT</title>
            <description>Patients who were treated with BMS at the index procedure and were randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
          </group>
        </group_list>
        <measure>
          <title>MACCE (Death, Myocardial Infarction or Stroke) - Randomized BMS ITT</title>
          <population>All randomized BMS ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 33 months or at last known follow-up, whichever was earlier.</population>
          <units>percentage of patients (KM estimate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="842"/>
                <count group_id="O2" value="845"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.68"/>
                    <measurement group_id="O2" value="5.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.91</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.58</ci_lower_limit>
            <ci_upper_limit>1.40</ci_upper_limit>
            <estimate_desc>30-month DAPT vs. 12-month DAPT; HR was stratified according to geographic region (NA, EU, or AU and NZ), thienopyridine drug received at the time of randomization, and presence or absence of risk factors for stent thrombosis</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Definite or Probable Stent Thrombosis (ST) - Randomized BMS ITT</title>
        <description>ST was assessed according to the Academic Research Consortium (ARC) definitions.</description>
        <time_frame>21 months (12-33 months post-index procedure)</time_frame>
        <population>All randomized BMS ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 33 months or at last known follow-up, whichever was earlier.</population>
        <group_list>
          <group group_id="O1">
            <title>BMS 30-month DAPT</title>
            <description>Patients who were treated with BMS at the index procedure and were randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
          </group>
          <group group_id="O2">
            <title>BMS 12-month DAPT</title>
            <description>Patients who were treated with BMS at the index procedure and were randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
          </group>
        </group_list>
        <measure>
          <title>Definite or Probable Stent Thrombosis (ST) - Randomized BMS ITT</title>
          <description>ST was assessed according to the Academic Research Consortium (ARC) definitions.</description>
          <population>All randomized BMS ITT patients; Patients were analyzed according to the treatment to which they were randomized (regardless of post-randomization compliance with the randomized treatment); Patients not experiencing the endpoint were censored at 33 months or at last known follow-up, whichever was earlier.</population>
          <units>percentage of patients (KM estimate)</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="842"/>
                <count group_id="O2" value="845"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.50"/>
                    <measurement group_id="O2" value="1.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.49</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.15</ci_lower_limit>
            <ci_upper_limit>1.64</ci_upper_limit>
            <estimate_desc>30-month DAPT vs. 12-month DAPT; HR was stratified according to geographic region (NA, EU, or AU and NZ), thienopyridine drug received at the time of randomization, and presence or absence of risk factors for stent thrombosis.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>GUSTO Severe or Moderate Bleeding - Randomized BMS ITT</title>
        <description>Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.</description>
        <time_frame>21 months (12-33 months post-index procedure)</time_frame>
        <population>Only patients who could be evaluated were included in this analysis (i.e., patients whose last contact date was 600 days after randomization or who had any adjudicated bleeding event at or before 630 days).</population>
        <group_list>
          <group group_id="O1">
            <title>BMS 30-month DAPT</title>
            <description>Patients who were treated with BMS at the index procedure and were randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
          </group>
          <group group_id="O2">
            <title>BMS 12-month DAPT</title>
            <description>Patients who were treated with BMS at the index procedure and were randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
          </group>
        </group_list>
        <measure>
          <title>GUSTO Severe or Moderate Bleeding - Randomized BMS ITT</title>
          <description>Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria.</description>
          <population>Only patients who could be evaluated were included in this analysis (i.e., patients whose last contact date was 600 days after randomization or who had any adjudicated bleeding event at or before 630 days).</population>
          <units>percentage of patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="766"/>
                <count group_id="O2" value="759"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.09"/>
                    <measurement group_id="O2" value="1.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>1.03</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.21</ci_lower_limit>
            <ci_upper_limit>2.28</ci_upper_limit>
            <estimate_desc>30-month DAPT vs. 12-month DAPT</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12-33 months post-index procedure (randomization to 33 months post-index procedure)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>HCRI DAPT - DES 30-month DAPT</title>
          <description>Patients who were enrolled by HCRI into the HCRI DAPT Study, treated with DES at the index procedure and randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
        </group>
        <group group_id="E2">
          <title>HCRI DAPT - DES 12-month DAPT</title>
          <description>Patients who were enrolled by HCRI into the HCRI DAPT Study, treated with DES at the index procedure and randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
        </group>
        <group group_id="E3">
          <title>HCRI DAPT - BMS 30-month DAPT</title>
          <description>Patients who were enrolled by HCRI into the HCRI DAPT Study, treated with BMS at the index procedure and randomized at 12 months post procedure to receive a total of 30 months of DAPT</description>
        </group>
        <group group_id="E4">
          <title>HCRI DAPT - BMS 12-month DAPT</title>
          <description>Patients who were enrolled by HCRI into the HCRI DAPT Study, treated with BMS at the index procedure and randomized at 12 months post procedure to receive a total of 12 months of DAPT</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="617" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="572" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="144" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="150" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ANAEMIA OF CHRONIC DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>COAGULOPATHY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>IRON DEFICIENCY ANAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RETROPERITONEAL LYMPHADENOPATHY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SPLENIC INFARCTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>THROMBOCYTOPENIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE CORONARY SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ANGINA PECTORIS</sub_title>
                <counts group_id="E1" subjects_affected="55" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="55" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="18" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ANGINA UNSTABLE</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>AORTIC VALVE INCOMPETENCE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ARRHYTHMIA</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ARTERIOSCLEROSIS CORONARY ARTERY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ARTERIOSPASM CORONARY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ATRIAL FIBRILLATION</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ATRIAL FLUTTER</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ATRIAL TACHYCARDIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ATRIOVENTRICULAR BLOCK</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ATRIOVENTRICULAR BLOCK COMPLETE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BRADYCARDIA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BUNDLE BRANCH BLOCK LEFT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CARDIAC ARREST</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CARDIAC DISORDER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE ACUTE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CARDIAC FAILURE CONGESTIVE</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CARDIO-RESPIRATORY ARREST</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CARDIOGENIC SHOCK</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CARDIOMYOPATHY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CARDIOPULMONARY FAILURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CONGESTIVE CARDIOMYOPATHY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY DISSECTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY OCCLUSION</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>EXTRASYSTOLES</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ISCHAEMIC CARDIOMYOPATHY</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LEFT VENTRICULAR DYSFUNCTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LEFT VENTRICULAR FAILURE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MITRAL VALVE INCOMPETENCE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MYOCARDIAL ISCHAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PALPITATIONS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PERICARDIAL EFFUSION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PERICARDITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SICK SINUS SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SUBENDOCARDIAL ISCHAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SUPRAVENTRICULAR EXTRASYSTOLES</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SUPRAVENTRICULAR TACHYCARDIA</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>TACHYCARDIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>VENTRICULAR FIBRILLATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>VENTRICULAR TACHYCARDIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>ARTERIOVENOUS MALFORMATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ATRIAL SEPTAL DEFECT</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYDROCELE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MYOTONIC DYSTROPHY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>EXOSTOSIS OF EXTERNAL EAR CANAL</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MENIERE'S DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>VERTIGO</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>HYPERPARATHYROIDISM</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYPOTHYROIDISM</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>THYROID MASS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>CATARACT</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>EYE PAIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GLAUCOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MACULAR DEGENERATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RETINAL DETACHMENT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RETINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>VISUAL ACUITY REDUCED</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL HERNIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN LOWER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN UPPER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>APHTHOUS STOMATITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ASCITES</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>COLITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>COLITIS ISCHAEMIC</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>COLITIS ULCERATIVE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CROHN'S DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DIVERTICULAR PERFORATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DIVERTICULUM</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DIVERTICULUM INTESTINAL HAEMORRHAGIC</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DUODENITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>EPIPLOIC APPENDAGITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GASTRIC ULCER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GASTRITIS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GASTRITIS EROSIVE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GASTROOESOPHAGEAL REFLUX DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HAEMATOCHEZIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HAEMORRHOIDAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HAEMORRHOIDS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HIATUS HERNIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>IMPAIRED GASTRIC EMPTYING</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INGUINAL HERNIA</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INGUINAL HERNIA, OBSTRUCTIVE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INTESTINAL ISCHAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INTESTINAL OBSTRUCTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LARGE INTESTINE PERFORATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LOWER GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MELAENA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL PERFORATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL SPASM</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>OESOPHAGITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PANCREATIC MASS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PANCREATIC PSEUDOCYST</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PANCREATITIS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PANCREATITIS ACUTE</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PHARYNGOESOPHAGEAL DIVERTICULUM</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>POLYP COLORECTAL</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RECTAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RECTAL POLYP</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SMALL INTESTINAL OBSTRUCTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SPIGELIAN HERNIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>UMBILICAL HERNIA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>UPPER GASTROINTESTINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>VOLVULUS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>ADVERSE DRUG REACTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ASTHENIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CHEST DISCOMFORT</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CHEST PAIN</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DEATH</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HERNIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HERNIA OBSTRUCTIVE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>NON-CARDIAC CHEST PAIN</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="51" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="12" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>OEDEMA PERIPHERAL</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PAIN</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PELVIC MASS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PYREXIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SWELLING</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SYSTEMIC INFLAMMATORY RESPONSE SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>ALCOHOLIC LIVER DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BILE DUCT OBSTRUCTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BILE DUCT STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BILE DUCT STONE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BILIARY COLIC</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CHOLANGITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CHOLECYSTITIS</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CHOLECYSTITIS ACUTE</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CHOLELITHIASIS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CHOLESTASIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CHRONIC HEPATIC FAILURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HEPATIC CIRRHOSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>ALLERGY TO METALS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL WALL ABSCESS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ABSCESS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ABSCESS LIMB</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ANAL ABSCESS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>APPENDICITIS</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>APPENDICITIS PERFORATED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ARTERIOVENOUS GRAFT SITE INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BACTERAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BRONCHIECTASIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BRONCHITIS</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BRONCHITIS BACTERIAL</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BRONCHOPNEUMONIA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CAMPYLOBACTER INTESTINAL INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CELLULITIS</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CELLULITIS STAPHYLOCOCCAL</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CHOLECYSTITIS INFECTIVE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CLOSTRIDIAL INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CLOSTRIDIUM DIFFICILE COLITIS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DIVERTICULITIS</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ERYSIPELAS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ESCHERICHIA URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GALLBLADDER ABSCESS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GANGRENE</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GASTRIC INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS VIRAL</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GIARDIASIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INFLUENZA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INTERVERTEBRAL DISCITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LOBAR PNEUMONIA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MASTOIDITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MENINGITIS ASEPTIC</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>NEUTROPENIC SEPSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>OSTEOMYELITIS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PANCREATIC ABSCESS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PHARYNGITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PILONIDAL CYST</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PNEUMONIA</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE WOUND INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PSEUDOMONAL SEPSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PSEUDOMONAS INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PYELONEPHRITIS</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PYELONEPHRITIS ACUTE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SEPSIS</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SEPSIS SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SINUSITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>STAPHYLOCOCCAL BACTERAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>STAPHYLOCOCCAL INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>STITCH ABSCESS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>UPPER RESPIRATORY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>UROSEPSIS</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>VIRAL INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>WOUND INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>BURNS THIRD DEGREE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CARTILAGE INJURY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CERVICAL VERTEBRAL FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CLAVICLE FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>COLLAPSE OF LUNG</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>COMPRESSION FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CONTUSION</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY RESTENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CYSTITIS RADIATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DEVICE MALFUNCTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>FALL</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>FEMORAL NECK FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>FEMUR FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>FOOT FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HEAD INJURY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HEPATIC HAEMATOMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HIP FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HUMERUS FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>IN-STENT ARTERIAL RESTENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>IN-STENT CORONARY ARTERY RESTENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INCISIONAL HERNIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INJURY</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>JOINT DISLOCATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LACERATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LIMB INJURY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LOWER LIMB FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MENISCUS LESION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MULTIPLE FRACTURES</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MUSCLE RUPTURE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>OVERDOSE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>POSTOPERATIVE ILEUS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PUBIC RAMI FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RIB FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ROAD TRAFFIC ACCIDENT</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SKIN LACERATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SPINAL CORD INJURY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SPINAL FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SUBDURAL HAEMATOMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SUBDURAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>TENDON INJURY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>TENDON RUPTURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>THERMAL BURN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>THORACIC VERTEBRAL FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>THROMBOSIS IN DEVICE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>UPPER LIMB FRACTURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>URETHRAL INJURY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>URINARY BLADDER RUPTURE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>VASCULAR BYPASS DYSFUNCTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>VASCULAR GRAFT OCCLUSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>VASCULAR PSEUDOANEURYSM</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>WOUND DEHISCENCE</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BLOOD CREATININE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BLOOD GLUCOSE FLUCTUATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BLOOD POTASSIUM INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BRONCHOSCOPY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>EJECTION FRACTION DECREASED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PROSTATIC SPECIFIC ANTIGEN INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>TROPONIN I INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>DEHYDRATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DIABETES MELLITUS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DIABETIC FOOT</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>FAILURE TO THRIVE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GOUT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYPERCALCAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYPERGLYCAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYPERKALAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYPOGLYCAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYPOKALAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYPONATRAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>METABOLIC ACIDOSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>OBESITY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>TYPE 2 DIABETES MELLITUS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ARTHRALGIA</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ARTHRITIS</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ARTHROPATHY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BACK PAIN</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CERVICAL SPINAL STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CHONDROCALCINOSIS PYROPHOSPHATE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>COMPARTMENT SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>COSTOCHONDRITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>FLANK PAIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>FOOT DEFORMITY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GOUTY ARTHRITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HAEMARTHROSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INTERVERTEBRAL DISC DEGENERATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INTERVERTEBRAL DISC DISORDER</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INTERVERTEBRAL DISC PROTRUSION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LUMBAR SPINAL STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MUSCLE SPASMS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MUSCULAR WEAKNESS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL CHEST PAIN</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>NECK PAIN</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>NEUROPATHIC ARTHROPATHY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>OSTEOARTHRITIS</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>OSTEOLYSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>OSTEOPOROSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PAIN IN EXTREMITY</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PAIN IN JAW</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RHABDOMYOLYSIS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RHEUMATOID ARTHRITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ROTATOR CUFF SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SPINAL COLUMN STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SPINAL OSTEOARTHRITIS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SPONDYLOARTHROPATHY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SPONDYLOLISTHESIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>TENDON DISORDER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>ACUTE MYELOID LEUKAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ADENOCARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ADENOCARCINOMA PANCREAS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ANGIOSARCOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>B-CELL LYMPHOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BASAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BENIGN DUODENAL NEOPLASM</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BLADDER CANCER</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BLADDER CANCER RECURRENT</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BLADDER TRANSITIONAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BRAIN NEOPLASM</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BREAST CANCER</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BREAST CANCER STAGE III</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CARCINOID TUMOUR OF THE SMALL BOWEL</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CARDIAC MYXOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CHRONIC LYMPHOCYTIC LEUKAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CHRONIC MYELOMONOCYTIC LEUKAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>COLON CANCER</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GASTRIC CANCER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HEPATIC NEOPLASM MALIGNANT</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INTRAVASCULAR PAPILLARY ENDOTHELIAL HYPERPLASIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LANGERHANS' CELL GRANULOMATOSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LENTIGO MALIGNA STAGE UNSPECIFIED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LIP AND/OR ORAL CAVITY CANCER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LIP NEOPLASM MALIGNANT STAGE UNSPECIFIED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LUNG CANCER METASTATIC</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LUNG NEOPLASM</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LUNG NEOPLASM MALIGNANT</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LYMPHOMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MALIGNANT MELANOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MALIGNANT MELANOMA STAGE II</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>METASTASES TO BONE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>METASTASES TO CENTRAL NERVOUS SYSTEM</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>METASTATIC NEOPLASM</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MULTIPLE MYELOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>NEOPLASM MALIGNANT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>NEOPLASM PROSTATE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>NON-HODGKIN'S LYMPHOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>NON-SMALL CELL LUNG CANCER</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>NON-SMALL CELL LUNG CANCER STAGE IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL ADENOCARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>OESOPHAGEAL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>OVARIAN CANCER METASTATIC</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PANCREATIC CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PITUITARY TUMOUR BENIGN</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PROSTATE CANCER</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PROSTATE CANCER METASTATIC</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RECTAL CANCER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RECTOSIGMOID CANCER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RENAL CANCER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RENAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SIGNET-RING CELL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SKIN CANCER</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SMALL CELL LUNG CANCER METASTATIC</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SQUAMOUS CELL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>THYROID CANCER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>TRANSITIONAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>ANOXIC ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>APHASIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ATAXIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BENIGN INTRACRANIAL HYPERTENSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CAROTID ARTERY STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CEREBRAL HAEMATOMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CEREBROVASCULAR ACCIDENT</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CERVICOBRACHIAL SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CONVULSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DEMENTIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DEMENTIA ALZHEIMER'S TYPE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DEMYELINATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DIABETIC NEUROPATHY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DIZZINESS</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>FACIAL PALSY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>GRAND MAL CONVULSION</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYPOAESTHESIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INTRACRANIAL ANEURYSM</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INTRACRANIAL HYPOTENSION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LOSS OF CONSCIOUSNESS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>METABOLIC ENCEPHALOPATHY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MIGRAINE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MYOCLONUS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>NEUROPATHY PERIPHERAL</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PARKINSON'S DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PERONEAL NERVE PALSY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>POST HERPETIC NEURALGIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>POST-TRAUMATIC EPILEPSY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PRESYNCOPE</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RADICULOPATHY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SCIATICA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SENSORY DISTURBANCE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SPINAL CLAUDICATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SPINAL CORD DISORDER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SUBARACHNOID HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SYNCOPE</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>TRANSIENT ISCHAEMIC ATTACK</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>VASCULAR DEMENTIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>VERTEBRAL ARTERY OCCLUSION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>PREGNANCY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>ALCOHOL WITHDRAWAL SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ALCOHOLISM</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ANXIETY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>COMPLETED SUICIDE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CONVERSION DISORDER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DELIRIUM TREMENS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DELUSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DEPRESSION</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DEPRESSIVE SYMPTOM</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MAJOR DEPRESSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MENTAL STATUS CHANGES</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PARANOIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PSYCHOTIC DISORDER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SUICIDAL IDEATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SUICIDE ATTEMPT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE PRERENAL FAILURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BLADDER MASS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BLADDER OBSTRUCTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CALCULUS URETERIC</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CALCULUS URINARY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DYSURIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HAEMATURIA</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HAEMORRHAGE URINARY TRACT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYDRONEPHROSIS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYDROURETER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYPERTONIC BLADDER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>NEPHROLITHIASIS</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>OBSTRUCTIVE UROPATHY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RENAL ARTERY STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RENAL COLIC</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RENAL CYST</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RENAL FAILURE</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RENAL FAILURE ACUTE</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RENAL FAILURE CHRONIC</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>URETERIC STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>URETHRAL OBSTRUCTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>URINARY RETENTION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>BENIGN PROSTATIC HYPERPLASIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>EPIDIDYMAL CYST</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>FEMALE GENITAL TRACT FISTULA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MENORRHAGIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>OVARIAN TORSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>POSTMENOPAUSAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PROSTATOMEGALY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE PULMONARY OEDEMA</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ACUTE RESPIRATORY FAILURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ASTHMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ATELECTASIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>BRONCHOSPASM</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>CHRONIC OBSTRUCTIVE PULMONARY DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>COUGH</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DYSPNOEA</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DYSPNOEA EXERTIONAL</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>EPISTAXIS</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HAEMOPTYSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYPERCAPNIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INTERSTITIAL LUNG DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LARYNGEAL STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>LARYNGOSPASM</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>NASAL SEPTUM DEVIATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>NASAL TURBINATE HYPERTROPHY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PLEURAL EFFUSION</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PLEURITIC PAIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PNEUMONIA ASPIRATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PNEUMOTHORAX</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PULMONARY ARTERIAL HYPERTENSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PULMONARY EMBOLISM</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PULMONARY FIBROSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PULMONARY MASS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PULMONARY OEDEMA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RESPIRATORY DISTRESS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RESPIRATORY FAILURE</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SLEEP APNOEA SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ANGIOEDEMA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DIABETIC ULCER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PEMPHIGOID</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RASH</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>RASH PAPULAR</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SKIN ULCER</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>CORONARY ARTERY BYPASS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>IMPLANTABLE DEFIBRILLATOR REPLACEMENT</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INGUINAL HERNIA REPAIR</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MITRAL VALVE REPLACEMENT</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>ANEURYSM</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>AORTIC ANEURYSM</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>AORTIC STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>AORTITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ARTERIAL OCCLUSIVE DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ARTERIAL STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ARTERIOSCLEROSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>DEEP VEIN THROMBOSIS</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>FEMORAL ARTERIAL STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>FEMORAL ARTERY OCCLUSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HAEMATOMA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYPERTENSIVE CRISIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYPERTENSIVE EMERGENCY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>HYPOTENSION</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ILIAC ARTERY OCCLUSION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>INTERMITTENT CLAUDICATION</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ISCHAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>MALIGNANT HYPERTENSION</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>ORTHOSTATIC HYPOTENSION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PELVIC VENOUS THROMBOSIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PERIPHERAL ARTERIAL OCCLUSIVE DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PERIPHERAL ISCHAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>PERIPHERAL VASCULAR DISORDER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>SUBCLAVIAN ARTERY STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>THROMBOPHLEBITIS SUPERFICIAL</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>THROMBOSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>VARICOSE VEIN</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
              <event>
                <sub_title>VASCULAR CALCIFICATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2642"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2634"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="842"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="845"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>AEs were not collected in the DAPT Trial</sub_title>
                <description>AEs that did not meet serious criteria were not routinely collected and reported by the investigators (only if they resulted in study discontinuation).</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Priscilla Driscoll Shempp, Sr. Director Trial Design, Development and Strategy</name_or_title>
      <organization>Harvard Clinical Research Institute</organization>
      <phone>617.307.5200</phone>
      <email>pdriscoll@hcri.harvard.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

